Exact Mass: 398.1995
Exact Mass Matches: 398.1995
Found 362 metabolites which its exact mass value is equals to given mass value 398.1995
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cinncassiol E
Cinncassiol E is found in herbs and spices. Cinncassiol E is a constituent of Cinnamomum cassia (Chinese cinnamon). Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol E is found in herbs and spices.
Galbanic acid
Galbanic acid is a constituent of Ferula gummosa (galbanum) and other Ferula species
Kamolonol
Constituent of Ferula assa-foetida (asafoetida). Kamolonol is found in herbs and spices and green vegetables. Kamolonol is found in green vegetables. Kamolonol is a constituent of Ferula assa-foetida (asafoetida).
Mammea C/AB cyclo D
Mammea C/AB cyclo D is found in fruits. Mammea C/AB cyclo D is isolated from Mammea americana (mamey). Isolated from Mammea americana (mamey). Mammea C/AB cyclo D is found in fruits.
Asacoumarin A
Isolated from Ferula assa-foetida (asafoetida). Asacoumarin A is found in herbs and spices and green vegetables. Asacoumarin A is found in green vegetables. Asacoumarin A is isolated from Ferula assa-foetida (asafoetida).
5-Hydroxy-8,8-dimethyl-6-(3-methyl-1-oxobutyl)-4-pentyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one
5-Hydroxy-8,8-dimethyl-6-(3-methyl-1-oxobutyl)-4-pentyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one is found in fruits. 5-Hydroxy-8,8-dimethyl-6-(3-methyl-1-oxobutyl)-4-pentyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one is isolated from Mammea americana (mamey). Isolated from Mammea americana (mamey). 5-Hydroxy-8,8-dimethyl-6-(3-methyl-1-oxobutyl)-4-pentyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one is found in fruits.
Armillaribin
Armillaribin is found in mushrooms. Armillaribin is a metabolite of Armillaria mellea (honey mushroom Metabolite of Armillaria mellea (honey mushroom). Armillaribin is found in mushrooms.
3'-Hydroxy-T2-triol
3-Hydroxy-T2-triol is a mycotoxin produced by Fusarium heterosporu
Ptaquiloside
D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
Bisantrene
D000970 - Antineoplastic Agents
Ferulsinaic acid
Methyl 4-[(E)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzenesulfonate
Taprostene
6,10,10-Trimethylspiro[bicyclo[7.2.0]undec-5-ene-2,2-oxirane]-4,8-diol 4-acetate 8-benzoate
Ferulsinaic acid
A member of the class of coumarins that is 2H-chromen-2-one substituted by a [(1R,2R,3S,5S)-2-(2-carboxyethyl)-2,5-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopentyl]methoxy group at position 7. It is isolated from the roots of Ferula sinaica.
3-Hydroxy-5-methyl-2-[8-oxo-9-hydroxyfarnesyl]-coumaran-3-one
(2R,3S,4S,9R,12R,13R,14S,15R,16R,17S)-3,4,12,13,15,16-hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-6-en-11-one
3-oxo-20beta,21beta-epoxy-resibufogenin|3-oxo-20S,21-epoxyresibufogenin
7-{5-[(1R,6S)-6-hydroxy-2,2,6-trimethyl-3-oxocyclohexyl]-3-methylpent-2-enyloxy}chromen-2-one|Kopeolone
4-[(2E)-7-Hydroxy-3,7-dimethyloct-2-enyl]-2,3,4,5-tetrahydroxy-trans-stilbene
(1S,5S,6R,7S,9R,10S)-5-methylbutanoyloxy-1,4,9-trihydroxy-2-oxoxanth-11-en-6,12-olide
2,3:6,7-dianhydro-1,4,5-trideoxy-1-[7-hydroxy-6-(2-methylbut-3-en-2-yl)-2-oxo-2H-chromen-3-yl]-3,7,7-trimethyl-D-erythro-heptitol|clauslactone U
2alpha-isovaleryloxy-3,8-dioxo-4beta,5alpha-dihydroxy-11-peroxybisabola-7(14),9E-diene
Di-Ac-19(4鈥樏傗垎3)-Abeo-11,12-dihydroxy-4(18),8,11,13-abietatetraen-7-one
1beta-(E-cinnamoyloxy)-6alpha-hydroxyisodrimeninol
7-methoxy-11,16-diketo-apian-8,14-dien-(22,6)-olide
3-O-acetyl-4,5-O-di-(2-methylbutyryl)-shikimic acid methyl ester|3-O-acetyl-4,5-O-di-<2-methylbutyryl>-shikimic acid methyl ester
(2E,10R)-tetradecaene-4,6-diyne-1,10,14-triol-1-O-beta-D-glucopyranoside
(1R,5S,8R)-1,3,5-trimethyl-8-((E)-2-oxohept-5-enyl)-2-((3E,5E)-2-oxohepta-3,5-dienyl)-6-oxabicyclo[3.2.1]oct-2-ene-4,7-dione|dihydrotrichodermolide
2,3-dihydro-7-hydroxy-2-(1-hydroxy-1,5,9-trimethyldeca-4,8-dienyl)furo[3,2-c]coumarin|fukanefuromarin L
3,4-dihydro-3,8-dihydroxy-2-(4,8-dimethylnona-3(E),7-dienyl)-2-methyl-2H-pyrano[3,2-c]coumarin|fukanefuromarin M
baigene A|rel-(2R,3R)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-3,4-dihydro-3,8-dihydroxy-2-methyl-2H,5H-[2,3-b][1]benzopyran-5-one
6-[(7-Coumarinyloxy)methyl]-alpha,2,3,6-tetramethyl-2-cyclohexene-1-butyric acid
Taprostene
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D002317 - Cardiovascular Agents
Beraprost
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C78568 - Prostaglandin Analogue
C24H30O5_2,4-Octadienoic acid, 6-methyl-, (1R,2S,7R,8aR)-7-(1-formylethenyl)-1,2,6,7,8,8a-hexahydro-7-hydroxy-1,8a-dimethyl-6-oxo-2-naphthalenyl ester, (2E,4E,6R)
C20H30O8_Picras-4-en-16-one, 1,2,11,12,14,15-hexahydroxy-, (1beta,2alpha,9xi,11beta,12alpha,15beta)
PTAQUILOSIDE
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 30 D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
Galbanic acid
Origin: Plant, Coumarins, Coumarin terpenoids, Sesquiterpenoids, Ferula terpenoids
(2R,3S,4S,9R,12R,13R,14S,15R,16R,17S)-3,4,12,13,15,16-hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-6-en-11-one_major
(2R,3S,4S,9R,12R,13R,14S,15R,16R,17S)-3,4,12,13,15,16-hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,?.0¹³,¹?]heptadec-6-en-11-one
Ala Ala His Thr
Ala Ala Thr His
Ala His Ala Thr
Ala His Thr Ala
Ala Thr Ala His
Ala Thr His Ala
Gly His Ser Val
Gly His Val Ser
Gly Ser His Val
Gly Ser Val His
Gly Val His Ser
Gly Val Ser His
His Ala Ala Thr
His Ala Thr Ala
His Gly Ser Val
His Gly Val Ser
His Ser Gly Val
His Ser Val Gly
His Thr Ala Ala
His Val Gly Ser
His Val Ser Gly
Ser Gly His Val
Ser Gly Val His
Ser His Gly Val
Ser His Val Gly
Ser Val Gly His
Ser Val His Gly
Thr Ala Ala His
Thr Ala His Ala
Thr His Ala Ala
Val Gly His Ser
Val Gly Ser His
Val His Gly Ser
Val His Ser Gly
Val Ser Gly His
Val Ser His Gly
Asacoumarin B
Armillaribin
Mammea C/AB cyclo D
Asacoumarin A
5-hydroxy-8,8-dimethyl-6-(3-methylbutanoyl)-4-pentyl-2H,8H-pyrano[2,3-h]chromen-2-one
3'-Hydroxy-T2-triol
Berkeleylactone C
Berkeleylactone D
17-alpha,21-Dihydroxy-16-alpha-Methylpregna-1,4,9(11)-Triene-3,20-Dione 21-Acetate
Flumedroxone
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CB - Corticosteroid derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-(2,4-difluorophenyl)- (9CI)
1,6-diisocyanatohexane,2-hydroxyethyl prop-2-enoate,oxepan-2-one
(alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]amino]carbonyl]amino]-4-Morpholinebutanoic acid Methyl ester
Ethylene glycol, diethylene glycol, maleic anhydride, dicyclopentadiene polymer
ethyl 3-[[4-(4-methylpiperazin-1-yl)benzoyl]amino]-5,6-dihydro-4H-pyrrolo[3,4-c]pyrazole-1-carboxylate
(3aS,3aS,8aR,8aR)-2,2-Cyclohexylidenebis[8,8a-dihydro-3aH-indeno[1,2-d]oxazole],99e.e.
3-(2-Naphthalen-1-yl-ethyl)-3-[2-(tetrahydro-pyran-2-yl)-ethyl]-pentanedioic acid
4-Tert-butyl-2-[(tert-butylamino)methyl]-6-[5-fluoro-6-(trifluoromethyl)pyridin-3-yl]phenol
(1-(2-Morpholin-4-ylethyl)indol-3-yl)-4-methylnaphthalen-1-ylmethanone
2-(2,6-dimethylmorpholine-4-carbonyl)-1-(3-methoxypropyl)pyrido[1,2-a]pyrrolo[2,3-d]pyrimidin-4(1H)-one
N-[(1r)-3-(4-Hydroxyphenyl)-1-Methylpropyl]-2-(2-Phenyl-1h-Indol-3-Yl)acetamide
N-{2-[6-(2,4-Diamino-6-ethylpyrimidin-5-YL)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-YL]ethyl}acetamide
Bisantrene
D000970 - Antineoplastic Agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
3,4,12,13,15,16-Hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.02,7.013,17]heptadec-6-en-11-one
[(2R,4aS,7aS,7bR)-3-formyl-6,6,7b-trimethyl-2,4,4a,5,7,7a-hexahydro-1H-cyclobuta[e]inden-2-yl] 2-hydroxy-4-methoxy-6-methylbenzoate
3-[1,3-Dimethyl-5-(2-methylprop-1-enyl)-2-[(2-oxochromen-7-yl)oxymethyl]cyclopentyl]propanoic acid
3-[(Z)-[4-[(E)-3-cyclohexyl-3-hydroxyprop-1-enyl]-5-hydroxy-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]methyl]benzoic acid
Methyl 4-[(E)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzenesulfonate
N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
N-[[(2S,3S,4R)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2S,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
N-ethyl-3-fluoro-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
N-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
(1R,5S)-3-(1,3-benzodioxol-5-ylmethyl)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
N-ethyl-3-fluoro-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-ethyl-3-fluoro-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-ethyl-3-fluoro-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-ethyl-3-fluoro-N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-[[(2S,3R,4R)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2R,3R,4S)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2R,3S,4S)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-12-(1,3-oxazol-4-ylmethyl)-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1R,9S,10S,11S)-10-(hydroxymethyl)-12-(1,3-oxazol-4-ylmethyl)-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1S,5R)-6-(1,3-benzodioxol-5-ylmethyl)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
2-[(3-Acetyloxy-2-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[2,3-Di(butanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-pentanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
(2R,3aR,7S)-7-hydroxy-2,5,7-trimethyl-3a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[3,7a-dihydro-2H-indene-6,1-cyclopropane]-1-one
5-Hydroxy-8,8-dimethyl-6-(3-methyl-1-oxobutyl)-4-pentyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one
(1r,2r,4s,5r,6s,9s,10r,11s,13s)-2,10,11-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylbutanoate
3-[(1r,2s,3s)-2,3-dimethyl-2-{[(2-oxochromen-7-yl)oxy]methyl}-6-(propan-2-ylidene)cyclohexyl]propanoic acid
7-{[(1r,2r,4r,4ar,5r,8as)-4-hydroxy-1,2,4a,5-tetramethyl-6-oxo-hexahydro-2h-naphthalen-1-yl]methoxy}chromen-2-one
7-{[(1r,2r,4r,4as,5r,8as)-4-hydroxy-1,2,4a,5-tetramethyl-6-oxo-hexahydro-2h-naphthalen-1-yl]methoxy}chromen-2-one
2-hydroxy-2-[(6e)-9-hydroxy-3,7,11-trimethyl-8-oxododeca-2,6,10-trien-1-yl]-4-methyl-1-benzofuran-3-one
7-{[(1r,2r,4as,8ar)-2-hydroxy-2,5,5,8a-tetramethyl-6-oxo-hexahydronaphthalen-1-yl]methoxy}chromen-2-one
7-{[(1s,2r,4ar,8as)-2-hydroxy-2,5,5,8a-tetramethyl-6-oxo-hexahydronaphthalen-1-yl]methoxy}chromen-2-one
3,6,9,10,15-pentahydroxy-6-(hydroxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one
(1r,3as,7s,9as,11ar)-3a,7-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde
3-[(1r,2r,3s,5s)-1,3-dimethyl-5-(2-methylprop-1-en-1-yl)-2-{[(2-oxochromen-7-yl)oxy]methyl}cyclopentyl]propanoic acid
7-{[(2e)-5-[(1r,2r,5s,8r)-2-hydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl]-3-methylpent-2-en-1-yl]oxy}chromen-2-one
2,11,12-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylbutanoate
(1r,2s,4s,5e,8s,9s)-4-(acetyloxy)-6,10,10-trimethylspiro[bicyclo[7.2.0]undecane-2,2'-oxiran]-5-en-8-yl benzoate
5-{3a,11-dihydroxy-9a,11a-dimethyl-7-oxo-1h,2h,3h,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}pyran-2-one
7-{[(1s,2r,4r,4as,5r,8as)-4-hydroxy-1,2,4a,5-tetramethyl-6-oxo-hexahydro-2h-naphthalen-1-yl]methoxy}chromen-2-one
2-hydroxy-2-(11-hydroxy-3,7,11-trimethyl-8-oxododeca-2,6,9-trien-1-yl)-4-methyl-1-benzofuran-3-one
(1r,3as,7s,9as,9bs,11ar)-3a,7-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde
5-[(1e)-2-(2,4-dihydroxyphenyl)ethenyl]-2-[(2e)-7-hydroxy-3,7-dimethyloct-2-en-1-yl]benzene-1,3-diol
(1s,2r,4s,5r,6s,9s,10s,11s,12s,13r)-2,11,12-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 3-methylbutanoate
(6ar)-3,6a-dimethyl-9-[(2s)-2-methyldecanoyl]furo[2,3-h]isochromene-6,8-dione
5-[(1r,3as,3br,9as,9bs,11ar)-3a-hydroxy-9a-(hydroxymethyl)-11a-methyl-7-oxo-1h,2h,3h,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
(2r)-2-hydroxy-2-[(2e,6e,9e)-11-hydroxy-3,7,11-trimethyl-8-oxododeca-2,6,9-trien-1-yl]-4-methyl-1-benzofuran-3-one
(1s,2s,5s,6r,7s,9r,10r,11r,13s,14s)-9,10,14-trihydroxy-5,9,14-trimethyl-4-oxo-3,12-dioxatetracyclo[8.4.0.0²,⁶.0¹¹,¹³]tetradecan-7-yl 2-methylbutanoate
(1r,4s,5r,6s,9r,10r,13s,14r,15s)-4,5,13,14-tetrahydroxy-4,9,13-trimethyl-18-methylidene-7,16-dioxatricyclo[13.3.0.0⁶,¹⁰]octadecane-8,17-dione
1,3,5-trimethyl-8-(2-oxohept-5-en-1-yl)-2-(2-oxohepta-3,5-dien-1-yl)-6-oxabicyclo[3.2.1]oct-2-ene-4,7-dione
3-oxo-11α-hydroxy-12-dehydroxy-scilliphaeo-sidin
{"Ingredient_id": "HBIN009395","Ingredient_name": "3-oxo-11\u03b1-hydroxy-12-dehydroxy-scilliphaeo-sidin","Alias": "NA","Ingredient_formula": "C24H30O5","Ingredient_Smile": "CC12CCC(=O)C=C1CCC3C2C(CC4(C3(CCC4C5=COC(=O)C=C5)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16338","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-oxo-20s,21-epoxyresibufogenin
{"Ingredient_id": "HBIN009399","Ingredient_name": "3-oxo-20s,21-epoxyresibufogenin","Alias": "NA","Ingredient_formula": "C24H30O5","Ingredient_Smile": "CC12CCC(=O)CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16318","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-[(2''e)-7''-hydroxy-3'',7''-dimethyloct-2''-enyl]-2',3,4',5-tetrahydroxy-trans-stilbene
{"Ingredient_id": "HBIN009876","Ingredient_name": "4-[(2''e)-7''-hydroxy-3'',7''-dimethyloct-2''-enyl]-2',3,4',5-tetrahydroxy-trans-stilbene","Alias": "NA","Ingredient_formula": "C24H30O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10053","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
assafoetidnol a
{"Ingredient_id": "HBIN017162","Ingredient_name": "assafoetidnol a","Alias": "NA","Ingredient_formula": "C24H30O5","Ingredient_Smile": "CC1(C(CCC2(C1C(CC(=C)C2COC3=CC4=C(C=C3)C=CC(=O)O4)O)C)O)C","Ingredient_weight": "398.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1910","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12041593","DrugBank_id": "NA"}